BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36966244)

  • 1. TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia.
    Winfree RL; Seto M; Dumitrescu L; Menon V; De Jager P; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ
    Acta Neuropathol; 2023 Jun; 145(6):733-747. PubMed ID: 36966244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
    Nguyen AT; Wang K; Hu G; Wang X; Miao Z; Azevedo JA; Suh E; Van Deerlin VM; Choi D; Roeder K; Li M; Lee EB
    Acta Neuropathol; 2020 Oct; 140(4):477-493. PubMed ID: 32840654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.
    Winfree RL; Nolan E; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Seto M; Petyuk VA; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ;
    Mol Neurodegener; 2024 May; 19(1):41. PubMed ID: 38760857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples.
    Prokop S; Miller KR; Labra SR; Pitkin RM; Hoxha K; Narasimhan S; Changolkar L; Rosenbloom A; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2019 Oct; 138(4):613-630. PubMed ID: 31350575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The age-related microglial transformation in Alzheimer's disease pathogenesis.
    Yuan C; Aierken A; Xie Z; Li N; Zhao J; Qing H
    Neurobiol Aging; 2020 Aug; 92():82-91. PubMed ID: 32408056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
    Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
    FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 13. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology.
    Fracassi A; Marcatti M; Tumurbaatar B; Woltjer R; Moreno S; Taglialatela G
    Brain Pathol; 2023 Jan; 33(1):e13108. PubMed ID: 35816404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2).
    Zhong L; Wang Z; Wang D; Wang Z; Martens YA; Wu L; Xu Y; Wang K; Li J; Huang R; Can D; Xu H; Bu G; Chen XF
    Mol Neurodegener; 2018 Mar; 13(1):15. PubMed ID: 29587871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
    Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
    Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer's Disease Mouse Model.
    Yuan Q; Liu X; Zhang Y; Xian YF; Zou J; Zhang X; Huang P; Song YQ; Lin ZX
    Molecules; 2021 May; 26(9):. PubMed ID: 34064330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
    Wang Y; Ulland TK; Ulrich JD; Song W; Tzaferis JA; Hole JT; Yuan P; Mahan TE; Shi Y; Gilfillan S; Cella M; Grutzendler J; DeMattos RB; Cirrito JR; Holtzman DM; Colonna M
    J Exp Med; 2016 May; 213(5):667-75. PubMed ID: 27091843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
    Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
    Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2, microglia, and Alzheimer's disease.
    Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
    Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.